Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: ORGO) | Delayed: 0.99 -0.04 (3.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $ | |||
| Open | $1.02 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $0.93 | EPS | $ | |||
| Volume | 1,340,141 | |||||
